Data as of Apr 17
| +0.02 / +0.27%|
The 7 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +88.68% increase from the last price of 7.42.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.